Portfolio News
Sofinnova MD Start
Moon Surgical (formerly MastOR) announces appointment of experienced core team to accelerate development
Moon Surgical, formerly MastOR, announced the addition of three seasoned medtech executives to the leadership team: Jeffery Alvarez as Chief Operating Officer, David Noonan as Chief Technology Officer, and Nicolas Linard as Head of Software.
Paris, France & San Francisco, California, USA, January 13th, 2021 -
Moon Surgical, formerly MastOR, is delighted to announce the addition of three seasoned medtech executives to the leadership team: Jeffery Alvarez as Chief Operating Officer, David Noonan as Chief Technology Officer, and Nicolas Linard as Head of Software. All three are experts in surgical robotics and computer vision, and were instrumental in the development, launch, and acquisition of highly successful companies in the medical device field.
Jeffery Alvarez is a brilliant problem solver. He was the first employee at medtech unicorn Auris Health (“Auris”), where he led the development and first clinical use of two surgical robotic platforms. An accomplished engineering leader, David Noonan, Ph.D., directed the systems, algorithms and robotics efforts at Auris for over five years. Nicolas Linard is a creative software architect with extensive experience in medical devices, robotics, and computer vision.
The three will join Anne Osdoit, Moon Surgical’s Chief Executive Officer, and the Sofinnova MD Start III team, to bolster their ambitions to reinvent laparoscopy procedures in the operating room.
"I am both thrilled and humbled to that we have been able to attract such experienced and successful leaders, which is a testament to our vision for Moon Surgical,” Ms. Osdoit noted. “With this phenomenal team, what we are building will be transformative to healthcare."
Moon Surgical aims to augment the surgeons with leaps forward in computer vision, haptics, and robotics, all uniquely configured in its proprietary platform. The development of this platform will beaccelerated with the arrival of the team's newest members, who will be working out of the company’s offices in the San Francisco Bay Area and in Paris, France.
Additionally, Moon Surgical has benefitted from the guidance of industry veterans Dan Wallace and David Schummers who have served as senior advisors since early 2020. As serial medical technology inventors, executives and entrepreneurs with vast experience in surgical robotics and instrumentation, they contribute to the strategic and technical growth of the company.
About Moon Surgical
Moon Surgical, based in Paris, France and San Carlos, California, is a pre-clinical stage medical device company established by Sofinnova MD Start III in 2020. It is focused on the development of a new platform dedicated to surgical assistance. www.moonsurgical.com
Contact info
Anne Osdoit
CEO, Moon Surgical
+33 (0) 6 60 42 28 31
Related News
Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization
Bioptimus Strengthens Commercial and Scientific Leadership with Key Hires
Pi-Cardia’s ShortCut™ becomes First Leaflet Modification Technology to receive CMS NTAP for Valve-in-Valve TAVR
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
Nuage Therapeutics welcomes Olivier Corminboeuf and Blandine Guimet to Leadership Team